Contact Us

ReNu Contact Solution
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

FDA: Reports on eye infection were delayed

May 17, 2006 | UPI

U.S. drug regulators claim Bausch & Lomb delayed informing them about reports linking its contact-lens solution to a rare eye infection.

The Wall Street Journal reported the Food and Drug Administration on its Web site said that Bausch & Lomb, which has headquarters in Rochester, N.Y., didn't initially tell the agency of reports the lens solution may be causing cases of Fusarium keratitis, an eye infection.

Earlier this week, the company announced a world-wide recall of the solution ReNu with MoistureLoc, which was being manufactured at its Greenville, S.C., plant, the Journal reported.

A Bausch & Lomb spokeswoman said the company "communicated promptly and directly with the agency regarding reports the company received about Fusarium infections."

Her statement said the company is working to take "immediate, appropriate corrective actions" to address the concerns raised in the FDA inspection, the Journal reported.

Related articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo